Basit öğe kaydını göster

dc.contributor.authorTopal, Hatice
dc.contributor.authorTopal, Yasar
dc.date.accessioned2020-11-20T16:19:04Z
dc.date.available2020-11-20T16:19:04Z
dc.date.issued2013
dc.identifier.issn2074-1804
dc.identifier.issn2074-1812
dc.identifier.urihttps://doi.org/10.5812/ircmj.12718
dc.identifier.urihttps://hdl.handle.net/20.500.12809/3688
dc.descriptionWOS: 000333960400021en_US
dc.descriptionPubMed ID: 24693390en_US
dc.description.abstractMethemoglobinemia is a disorder characterized by the presence of a higher than normal level of methemoglobin. Prilocaine which is one of the oxidizing local anaesthetics is widely used in many local procedures. The first choice of treatment of complications due to the use of these local anaesthetics is methylene blue, while ascorbic acid is the alternative choice. The side effects of metilen blue restrict its usage in some special conditions. Ascorbic acid is a good alternative drug with limited experience in methemoglobinemia. We present a case of a methemoglobinemia treated with ascorbic acid successfully to emphasize the use of ascorbic acid as an alternative method.en_US
dc.item-language.isoengen_US
dc.publisherKowsar Publen_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMethemoglobinemiaen_US
dc.subjectPrilocaineen_US
dc.subjectAscorbic Aciden_US
dc.titleToxic Methemoglobinemia Treated With Ascorbic Acid: Case Reporten_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTemp[Topal, Hatice; Topal, Yasar] Mugla Sitki Kocman Univ, Fac Med, Dept Pediat, Mugla, Turkeyen_US
dc.identifier.doi10.5812/ircmj.12718
dc.identifier.volume15en_US
dc.identifier.issue12en_US
dc.relation.journalIranian Red Crescent Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster